Silbergeld D L, Rostomily R C, Alvord E C
Department of Neurological Surgery, University of Washington Medical Center, Seattle 98195.
J Neurooncol. 1991 Apr;10(2):179-85. doi: 10.1007/BF00146880.
To delineate the causes of death (COD) in adults with supratentorial glioblastoma multiforme (GM) we reviewed 117 consecutive cases examined at autopsy over a nineteen year period at the University of Washington. Twenty cases (17%) had expired unexpectedly without ante mortem diagnosis, 5 patients (4%) had been diagnosed as having lower grade astrocytomas prior to death. Other than the 20 patients without ante mortem diagnosis, all patients had a surgical procedure for treatment and/or diagnosis (biopsy 10%, craniotomy 90%). Postsurgical therapy varied, but there was no significant difference in median length of survival among the different treatment groups. Factors considered as potential COD were: herniation (axial, transtentorial, subfalcine, tonsillar), surgical complications (death within thirty days of surgery secondary to cerebral hemorrhage and/or edema), severe systemic illness, brainstem invasion by tumor, and neutron-induced cerebral injury (cerebral and brainstem gliosis were evident in these cases). A potential COD could be identified in 93% of patients. Patients with no ante mortem diagnosis were likely to have herniated (p = 0.01), whereas patients who underwent neutron irradiation were unlikely to have herniated (p = 0.001). No other variables were statistically significant predictors of herniation, including multifocal tumors (20 patients), and brainstem invasion by tumor (18 patients). No patients died as a result of treatment except those who underwent neutron radiotherapy and those who died postoperatively. Although significant mass effect, as evidenced by herniation, was apparent in 61% of patients, most of these patients had an additional identifiable COD. We conclude that the COD in patients with GM varies and is multifactorial.
为了明确幕上多形性胶质母细胞瘤(GM)成年患者的死因(COD),我们回顾了华盛顿大学19年间连续尸检的117例病例。20例(17%)患者意外死亡且生前未确诊,5例(4%)患者在死亡前被诊断为低级别星形细胞瘤。除了20例生前未确诊的患者外,所有患者均接受了手术治疗和/或诊断(活检10%,开颅手术90%)。术后治疗方式各异,但不同治疗组的中位生存期无显著差异。被视为潜在COD的因素包括:脑疝(轴性、经天幕、大脑镰下、小脑扁桃体疝)、手术并发症(术后30天内死于脑出血和/或水肿)、严重全身性疾病、肿瘤侵犯脑干以及中子诱发的脑损伤(这些病例中脑和脑干胶质增生明显)。93%的患者可确定潜在的COD。生前未确诊的患者更易发生脑疝(p = 0.01),而接受中子照射的患者不易发生脑疝(p = 0.001)。没有其他变量是脑疝的统计学显著预测因素,包括多灶性肿瘤(20例患者)和肿瘤侵犯脑干(18例患者)。除了接受中子放疗的患者和术后死亡的患者外,没有患者因治疗死亡。尽管61%的患者出现了明显的占位效应,如脑疝,但这些患者大多还有其他可识别的COD。我们得出结论,GM患者的COD各不相同且是多因素的。